Alexis LeVee

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Transcription Factor

Locally Advanced

Advanced Non Small Cell Lung Cancer

Prostate Cancer

Top Venues

OncoTargets and therapy

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Alexis LeVee, Joanne E Mortimer
The Challenges of Treating Patients with Breast Cancer and Obesity. Cancers 15 (9) (2023)
Alexis LeVee, Kellie Spector, Brigid Larkin, Felipe Dezem, Jasmine Plummer, Farnaz Dadmanesh, Sujata Patil, Heather L McArthur
Incidence and prognostic impact of HER2-positivity loss after dual HER2-directed neoadjuvant therapy for HER2+ breast cancer. Cancer medicine (2023)
Alexis LeVee, Joanne E Mortimer
The Challenges of Treating Patients with Breast Cancer and Obesity. Cancers 15 (9) (2023)
Alexis LeVee, Ching Ying Lin, Edwin Posadas, Robert Figlin, Neil A Bhowmick, Dolores Di Vizio, Leigh Ellis, Charlos J Rosser, Michael R Freeman, Dan Theodorescu, Stephen J Freedland, Jun Gong
Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. OncoTargets and therapy 14 (2021)